SW209415

SW209415 is a drug that acts as a potent inhibitor of the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH), which increases levels of prostaglandin E2 and promotes tissue regeneration.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

SW209415 is a drug that acts as a potent inhibitor of the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH), which increases levels of prostaglandin E2 and promotes tissue regeneration. The (R) or (+) enantiomer is the more active.

It has similar potency in vitro to the earlier and better studied related compound SW033291, but its solubility is far higher and its pharmacokinetic properties and bioavailability significantly improved, making it more suitable for development for potential clinical applications. It is being researched for improved healing of broken bones and accelerating recovery from bone marrow transplant.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368851161 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.